Erlotinib Tablets

Get a Price/Quote

Erlotinib Tablets Specification

Indication
Non-Small Cell Lung Cancer (NSCLC), Pancreatic Cancer

Salt Composition
Erlotinib Hydrochloride

Dosage Form
Tablet

Feature
Oral Targeted Therapy

Ingredients
Erlotinib Hydrochloride, Excipients

Application
Anticancer Therapy

Physical Color/Texture
White to off-white circular tablets

Storage Instructions
Store below 30C, protect from moisture and light

Shelf Life
24 Months

Erlotinib Tablets Trade Information

FOB Port
All Indian Port

Payment Terms
Western Union, Paypal, Telegraphic Transfer (T/T), Cash in Advance (CID)

Delivery Time
7 Days

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
As Per Standard Packing

Main Export Market(s)
Asia, Australia, North America, South America, Eastern Europe, Western Europe, Middle East, Africa, Central America

Certifications
ISO, GMP, WHO

About Erlotinib Tablets

Product Name : Erlotinib Tablets
Trade Name : Erlonat, Erlocip, Tarceva
Available Strength : 100 mg, 150 mg
Packing : 30 Tablets/Bottle
Pack Insert/Leaflet : Yes
Therapeutic use : Anti Cancer
Production Capacity : 1 million tablet/month

What is Erlotinib ?
Erlotinib Tablet is a medicine that is used for the treatment of Non-Small Cell Lung Cancer, Chemotherapy, Pancreatic Cancer and other conditions.
Erlotinib Tablet contains Erlotinib as an active ingredient.
Erlotinib Tablet works by inhibiting the activity of protein to prevent the growth and spread of cancer cells.
Detailed information related to Erlotinib Tablets uses, composition, dosage, side effects and reviews is listed below.

Erlotinib Tablet Uses
Erlotinib Tablet is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms:

Non-Small Cell Lung Cancer
Chemotherapy
Pancreatic Cancer

Erlotinib Tablet Working, Mechanism of Action and Pharmacology
Erlotinib Tablet improves the patients condition by performing the following functions:

Inhibiting the activity of protein to prevent the growth and spread of cancer cells.

Erlotinib Tablet Composition and Active Ingredients
Erlotinib Tablet is composed of the following active ingredients (salts)

Erlotinib (100Mg)

Please note that this medicine may be available in various strengths for each active ingredient listed above.

Erlotinib Tablet Side-effects
The following is a list of possible side-effects that may occur from all constituting ingredients of Erlotinib Tablet. This is not a comprehensive list. These side-effects are possible, but do not always occur. Some of the side-effects may be rare but serious. Consult your doctor if you observe any of the following side-effects, especially if they do not go away.

Dry Skin
Cough
Fatigue
Alopecia
Nausea
Folliculitis

Erlotinib Tablet Precautions & How to Use
Before using this drug, inform your doctor about your current list of medications, over the counter products (e.g. vitamins, herbal supplements, etc.), allergies, pre-existing diseases, and current health conditions (e.g. pregnancy, upcoming surgery, etc.). Some health conditions may make you more susceptible to the side-effects of the drug. Take as directed by your doctor or follow the direction printed on the product insert. Dosage is based on your condition. Tell your doctor if your condition persists or worsens. Important counseling points are listed below.

Breathing difficulty
Contact lenses
Increased eye watering
Intolerance to some sugars
Liver or kidney problems
Loss of appetite

Advanced Oral Targeted Therapy

Erlotinib Tablets offer an innovative approach to cancer treatment by targeting specific proteins responsible for tumor growth. Their oral administration provides convenience for patients, making ongoing therapy manageable and less invasive compared to intravenous treatments. The medication is part of the evolving arsenal against NSCLC and pancreatic cancer, supporting improved patient outcomes.

Quality and Safety Assured

Every box of Erlotinib Tablets is manufactured following stringent quality control measures in India, ensuring safety and efficacy. These tablets are approved by respective drug authorities and delivered in secure packaging to maintain integrity. Storage below 30C and protection from moisture and light safeguard the medicines effectiveness throughout its 24-month shelf life.

FAQs of Erlotinib Tablets:

Q: How should Erlotinib Tablets be taken for cancer therapy?

A: Erlotinib Tablets should be taken orally, as directed by your physician, usually once daily before or after meals. Consistent dosing at the same time each day helps maintain effective drug levels. Consultation with your doctor regarding any missed doses or potential side effects is essential.

Q: What types of cancer are treated with Erlotinib Tablets?

A: Erlotinib Tablets are primarily prescribed for non-small cell lung cancer (NSCLC) and pancreatic cancer. The therapy targets specific pathways in cancer cells, inhibiting their growth and proliferation to improve patient outcomes.

Q: When is a prescription required for Erlotinib Tablets?

A: A prescription is mandatory for obtaining Erlotinib Tablets. Medical professionals will evaluate your diagnosis and overall health before prescribing this anticancer therapy to ensure safe and appropriate use.

Q: Where should Erlotinib Tablets be stored for optimal efficacy?

A: Store Erlotinib Tablets below 30C, protected from moisture and light, to maintain their potency. Keeping the tablets in their original packaging and away from direct sunlight or humid areas extends shelf life and prevents degradation.

Q: What is the process for exporting Erlotinib Tablets from India?

A: Exporters and manufacturers in India comply with international regulations and quality standards for Erlotinib Tablets production, packaging, and shipment. Product registration and approval by drug authorities are prerequisites for export to ensure safety and efficacy in global markets.

Q: What are the benefits of using Erlotinib Tablets for anticancer therapy?

A: Erlotinib Tablets provide targeted cancer treatment with fewer side effects compared to traditional chemotherapy. Their oral administration offers convenience, and the therapy is recognized for its ability to hinder cancer cell growth in NSCLC and pancreatic cancer, improving quality of life.

Tell us about your requirement